Home
About
Overview
Sharing Data
ORCID
Help
History (25)
Treatment Effectiveness in Heart Failure with Comorbidity: Lung Disease and Kidney Disease.
Quantifying and mitigating motor phenotypes induced by antisense oligonucleotides in the central nervous system.
SWOG S0709: Randomized Phase II Trial of Erlotinib versus Erlotinib Plus Carboplatin/Paclitaxel in Patients with Advanced Non-Small Cell Lung Cancer and Impaired Performance Status as Selected by a Serum Proteomics Assay.
Immunologic and clinical features of 25 Amish patients with RMRP 70 A-->G cartilage hair hypoplasia.
Outcome Measures in Facioscapulohumeral Muscular Dystrophy Clinical Trials.
See All 25 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Outcome Measures in Facioscapulohumeral Muscular Dystrophy Clinical Trials.
Ghasemi M, Emerson CP, Hayward LJ. Outcome Measures in Facioscapulohumeral Muscular Dystrophy Clinical Trials. Cells. 2022 02 16; 11(4).
View in:
PubMed
subject areas
Homeodomain Proteins
Humans
Muscle, Skeletal
Muscular Dystrophy, Facioscapulohumeral
authors with profiles
Lawrence J Hayward MD, PhD
Charles P Emerson Jr. PhD